Syensqo today announces that it has initiated a strategic review of its Performance & Care segment. This is aligned with the Company’s intention to focus on becoming a pure play specialty materials and advanced technologies company, with a greater exposure to structurally attractive end markets including aerospace and defence, electronics, healthcare, energy and advanced mobility applications.
The Company has not set a defined timetable for the strategic review, and will provide further updates when appropriate. In addition, there can be no assurance or certainty that this process will result in any transaction, nor as to the terms or structure of any transaction.
Syensqo‘s Performance & Care segment, comprising the Novecare and Technology Solutions global business units, is a global leader in surface chemistry solutions and specialty mining reagents serving the consumer care, agro, coatings and mining end markets. In 2025, the segment generated net sales of €2.0 billion and an underlying EBITDA of €358 million.
Syensqo Sharpens Portfolio Focus Towards Specialty Materials
This latest strategic move follows a series of governance and leadership changes at Syensqo, including the appointment of Heike van de Kerkhof as Chair of the Board of Directors earlier this year, as the company continues to sharpen its focus on high-growth technology end markets.
Since the start of the year, and along with the Board, we have undertaken a strategic assessment of our long-term direction and value creation priorities. In addition, we are fully focused on accelerating our growth trajectory, driving more consistent execution, sharpening our capital discipline as well as improving cash flow delivery.”
— Mike Radossich, Chief Executive Officer, Syensqo
Today’s announcement reflects our intention to further sharpen our portfolio, increase our focus on technologies where we see the strongest long-term growth opportunities and drive sustained, innovation-led differentiation. Accordingly, we will now evaluate a range of strategic options for the Performance & Care segment, with an emphasis on maximizing long-term value for our shareholders.”
— Mike Radossich, Chief Executive Officer, Syensqo
For more information, visit Syensqo.